Nephrocare Health Services Limited (BOM:544647)

India · Delayed Price · Currency is INR

694.20

+19.50 (2.89%)

At close: Aug 21, 2026

BOM:544647 Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	10,537	9,988	7,558	5,662	4,373	3,169
Revenue Growth	39.41%	32.16%	33.50%	29.47%	37.99%	11.40%
Gross Profit	4,091	3,794	2,673	1,832	1,142	1,290
Operating Income	1,510	1,388	956.04	476.58	17.16	-186.26
Net Income	851.1	768.4	670.96	351.33	-117.89	-219.75
Earnings Per Share	8.63	8.10	8.01	4.40	-1.53	-26.51
EPS Growth	7.75%	1.12%	82.05%	-	-	-

Revenue by Geography

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	5,813	5,155	4,315	3,861	3,169
Uzbekistan	1,004	733.95	664.95	168.5	-
Philippines	3,112	1,665	681.21	343.34	-
Others	-	3.71	-	-	-
Nepal	58.74	-	-	-	-
Total	9,988	7,558	5,662	4,373	3,169

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	4,256	4,256	1,884	782.46	660.53	1,281
Total Debt	797.07	797.07	2,578	2,678	2,137	1,197
Net Cash (Debt)	3,459	3,459	-693.53	-1,896	-1,477	83.35
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	35.08	36.47	-8.28	-23.72	-19.17	10.05

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-	2,326	1,353	722.8	112.69	119.18
Capital Expenditures	-	-1,189	-997.75	-773.49	-715.69	-429.7
Free Cash Flow	-	1,136	355.72	-50.69	-603	-310.52
Free Cash Flow Growth	-	219.47%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	38.82%	37.98%	35.36%	32.36%	26.12%	40.70%
Operating Margin	14.33%	13.90%	12.65%	8.42%	0.39%	-5.88%
Pretax Margin	10.44%	9.76%	11.57%	5.86%	-1.96%	-8.86%
Profit Margin	8.08%	7.69%	8.88%	6.21%	-2.70%	-6.93%
FCF Margin	-	11.38%	4.71%	-0.90%	-13.79%	-9.80%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 22, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	81.83	66.19	-	-	-	-
P/FCF Ratio	61.29	44.75	-	-	-	-
PS Ratio	6.61	5.09	-	-	-	-